Top Markets
Coin of the day
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Pozycja w akcjach #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Cena akcji
$0.04895618
Ostatnia synchronizacja: 2025-03-18
Kapitalizacja rynkowa
$5.55M
Zmiana (1 dzień)
-0.04%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel WPD Pharmaceuticals Inc. (WBIO)

Kategoria

Historia ceny akcji dla WPD Pharmaceuticals Inc. (WBIO)
Najwyższa cena zamknięcia: $0.05 dnia 2025-03-01

Najniższa cena zamknięcia: $3.04 dnia 2009-02-01
Historia cen akcji firmy WPD Pharmaceuticals Inc. od 2009 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2025 -53.70%
2024 -87.50%
2023 1.29%
2022 -30.97%
2021 -78.43%
2020 -23.84%
2019 14.02%
2018 -26.68%
2017 2,566.34%
2016 2.72%
2015 17.86%
2014 -23.02%
2013 -38.03%
2012 -49.89%
2011 -37.12%
2010 -30.81%
2009 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE